Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Jefferson Research
Provider: Sadif Analytics Prime
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Auxilium Pharmaceuticals Inc raises upper end of prior FY 2013 revenue guidance; gives FY 2013 net income guidance in line with analysts' estimates - Conference Call

Monday, 10 Feb 2014 09:00am EST 

Auxilium Pharmaceuticals Inc:Expects FY 2013 total revenues of between $370 million and $401 million.Expects FY 2013 non-GAAP net income in a range of $25 million to $30 million.FY 2013 revenue of $387 million and net income of $29 million - Thomson Reuters I/B/E/S. 

Company Quote

-0.06 -0.16%
29 Jan 2015